Autologous bone marrow stromal cells are promising candidates for cell therapy approaches to treat bone degeneration in sickle cell disease.
暂无分享,去创建一个
P. Bierling | F. Galactéros | P. Hernigou | A. Poignard | Y. Homma | N. Chevallier | H. Rouard | N. Jullien | Angélique Lebouvier | Laura Coquelin-Salsac | J. Léotot
[1] P. Bianco,et al. Skeletal stem cells , 2015, Development.
[2] J. Christian,et al. Sickle cell disease and perioperative considerations: review and retrospective report. , 2013, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[3] A. Caplan,et al. Mesenchymal Stem Cells in Tissue Repair , 2013, Front. Immunol..
[4] D. Phinney. Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy , 2012, Journal of cellular biochemistry.
[5] Philippe Bierling,et al. In vivo and in vitro comparison of three different allografts vitalized with human mesenchymal stromal cells. , 2012, Tissue engineering. Part A.
[6] J. Hui,et al. Improved mesenchymal stem cells attachment and in vitro cartilage tissue formation on chitosan-modified poly(L-lactide-co-epsilon-caprolactone) scaffold. , 2012, Tissue engineering. Part A.
[7] F. Galactéros,et al. The natural progression of symptomatic humeral head osteonecrosis in adults with sickle cell disease. , 2012, The Journal of bone and joint surgery. American volume.
[8] J. García-Sancho,et al. Intervertebral Disc Repair by Autologous Mesenchymal Bone Marrow Cells: A Pilot Study , 2011, Transplantation.
[9] P. Kasten,et al. Prediction of in vivo bone forming potency of bone marrow-derived human mesenchymal stem cells. , 2011, European cells & materials.
[10] Y. St-Pierre,et al. Bidirectional interactions between bone metabolism and hematopoiesis. , 2011, Experimental hematology.
[11] C. Jorgensen,et al. Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology , 2011, Stem Cell Research & Therapy.
[12] J. Fischer,et al. Bridging the gap: Bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[13] A. Bolarinwa,et al. Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease , 2009, International Orthopaedics.
[14] P. Hernigou,et al. Multifocal Joint Osteonecrosis in Sickle Cell Disease , 2009, The open orthopaedics journal.
[15] P. Hernigou,et al. Percutaneous Implantation of Autologous Bone Marrow Osteoprogenitor Cells as Treatment of Bone Avascular Necrosis Related to Sickle Cell Disease , 2008, The open orthopaedics journal.
[16] P. Robey,et al. Formation of hematopoietic territories and bone by transplanted human bone marrow stromal cells requires a critical cell density. , 2007, Experimental hematology.
[17] A. Cometa,et al. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell‐therapy approaches: Further insights in the search for a fetal calf serum substitute , 2007, Journal of cellular physiology.
[18] D. Bachir,et al. The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease. , 2006, The Journal of bone and joint surgery. American volume.
[19] X. Holy,et al. Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell‐based therapy applications , 2005, Journal of cellular physiology.
[20] N. Fisk,et al. Fetal stem cells. , 2004, Best practice & research. Clinical obstetrics & gynaecology.
[21] S. Both,et al. Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells , 2004, Journal of materials science. Materials in medicine.
[22] D. Prockop,et al. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. , 2004, Analytical biochemistry.
[23] Celso Matos,et al. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. , 2004, The Journal of bone and joint surgery. American volume.
[24] Ching-Chuan Jiang,et al. Multipotential Mesenchymal Stem Cells from Femoral Bone Marrow Near the Site of Osteonecrosis , 2003, Stem cells.
[25] P. Hernigou,et al. Treatment of Osteonecrosis With Autologous Bone Marrow Grafting , 2002, Clinical orthopaedics and related research.
[26] P. Robey,et al. EFFECT OF SERUM ON HUMAN BONE MARROW STROMAL CELLS: EX VIVO EXPANSION AND IN VIVO BONE FORMATION , 2000, Transplantation.
[27] E. Vichinsky,et al. The perioperative complication rate of orthopedic surgery in sickle cell disease: Report of the national sickle cell surgery study group , 1999, American journal of hematology.
[28] R. Cancedda,et al. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. , 1999, Experimental hematology.
[29] P. Schiller,et al. Age‐Related Osteogenic Potential of Mesenchymal Stromal Stem Cells from Human Vertebral Bone Marrow , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[30] P. Hernigou,et al. Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis. , 1999, The Journal of bone and joint surgery. British volume.
[31] P. Bianco,et al. Diseases of Bone and the Stromal Cell Lineage , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[32] P. Lane. Sickle cell disease. , 1996, Pediatric clinics of North America.
[33] N. Uike,et al. Establishment of a human myeloma cell line with growth-promoting activity for bone marrow-derived fibroblastoid colony-forming cells. , 1994, Experimental hematology.
[34] L. Sleeper,et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. , 1991, The New England journal of medicine.
[35] Graham R Serjeant,et al. Sickle-cell disease , 1984, The Lancet.
[36] M. Marcacci,et al. Bone regeneration with mesenchymal stem cells. , 2012, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.
[37] Casey K Chan,et al. Stem cell homing in musculoskeletal injury. , 2011, Biomaterials.
[38] Philippe Bierling,et al. Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. , 2010, Biomaterials.
[39] P. Hernigou,et al. Cell therapy of hip osteonecrosis with autologous bone marrow grafting , 2009, Indian journal of orthopaedics.
[40] P. Bianco,et al. Enumeration of the colony-forming units-fibroblast from mouse and human bone marrow in normal and pathological conditions. , 2009, Stem cell research.
[41] Wen-jian Zhang,et al. Decreased proliferation of mesenchymal stem cells in corticosteroid-induced osteonecrosis of femoral head. , 2008, Orthopedics.
[42] D. Prockop,et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.
[43] A. Marti-Carvajal,et al. Treatment for avascular necrosis of bone in people with sickle cell disease. , 2004, The Cochrane database of systematic reviews.
[44] A. Carr,et al. Patients with primary osteoarthritis show no change with ageing in the number of osteogenic precursors. , 1998, Scandinavian journal of rheumatology.
[45] Rm,et al. Sickle cell disease , 1996 .
[46] I. M. Vertkin,et al. Risk Factors , 2007, Morality and Ethics at War.
[47] C Argote-Olivera,et al. [Sickle-cell anemia]. , 1977, La Prensa medica mexicana.